Geneva, March 20 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000060751) titled 'Comparative Efficacy and Safety of Vornorexant in Insomnia Patients with Type 2 Diabetes' on Feb. 26.

Study Type: Observational

Study Design: Not selected Not selected

Primary Sponsor: Other

Condition: Insomnia

Recruitment Status: Not Recruiting

Phase: Not selected

Date of First Enrollment: 2026/02/26

Target Sample Size: 50

Countries of Recruitment: Japan

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069517

Published by HT Digital Content Services with permission from Health Daily Digest....